La Jolla Pharmaceutical Company

NasdaqCM:LJPC Stok Raporu

Piyasa değeri: US$155.1m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

La Jolla Pharmaceutical Yönetim

Yönetim kriter kontrolleri 3/4

La Jolla Pharmaceutical CEO'su Larry Edwards, Jul2020 tarihinde atandı, in görev süresi 2.08 yıldır. in toplam yıllık tazminatı $ 2.39M olup, şirket hissesi ve opsiyonları dahil olmak üzere 23% maaş ve 77% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.048% ine doğrudan sahiptir ve bu hisseler $ 74.45K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.1 yıl ve 7.7 yıldır.

Anahtar bilgiler

Larry Edwards

İcra Kurulu Başkanı

US$2.4m

Toplam tazminat

CEO maaş yüzdesi23.0%
CEO görev süresi2.1yrs
CEO sahipliği0.05%
Yönetim ortalama görev süresi2.1yrs
Yönetim Kurulu ortalama görev süresi7.7yrs

Son yönetim güncellemeleri

Should You Take Comfort From Insider Transactions At La Jolla Pharmaceutical Company (NASDAQ:LJPC)?

Jan 05
Should You Take Comfort From Insider Transactions At La Jolla Pharmaceutical Company (NASDAQ:LJPC)?

Recent updates

Innoviva to acquire La Jolla Pharma for $149M including debt

Jul 11

We Think La Jolla Pharmaceutical's (NASDAQ:LJPC) Robust Earnings Are Conservative

Nov 11
We Think La Jolla Pharmaceutical's (NASDAQ:LJPC) Robust Earnings Are Conservative

Our Take On La Jolla Pharmaceutical Company

Jul 02

La Jolla Pharmaceutical EPS misses by $0.14, beats on revenue

May 07

La Jolla Pharmaceutical's (NASDAQ:LJPC) Shareholders Are Down 82% On Their Shares

Mar 11
La Jolla Pharmaceutical's (NASDAQ:LJPC) Shareholders Are Down 82% On Their Shares

Market Sentiment Around Loss-Making La Jolla Pharmaceutical Company (NASDAQ:LJPC)

Feb 11
Market Sentiment Around Loss-Making La Jolla Pharmaceutical Company (NASDAQ:LJPC)

Industry Analysts Just Upgraded Their La Jolla Pharmaceutical Company (NASDAQ:LJPC) Revenue Forecasts By 18%

Jan 16
Industry Analysts Just Upgraded Their La Jolla Pharmaceutical Company (NASDAQ:LJPC) Revenue Forecasts By 18%

La Jolla Pharmaceutical rallies on exclusive licensing agreement with PAION

Jan 12

Should You Take Comfort From Insider Transactions At La Jolla Pharmaceutical Company (NASDAQ:LJPC)?

Jan 05
Should You Take Comfort From Insider Transactions At La Jolla Pharmaceutical Company (NASDAQ:LJPC)?

Could The La Jolla Pharmaceutical Company (NASDAQ:LJPC) Ownership Structure Tell Us Something Useful?

Dec 09
Could The La Jolla Pharmaceutical Company (NASDAQ:LJPC) Ownership Structure Tell Us Something Useful?

La Jolla Pharmaceutical EPS beats by $0.11, beats on revenue

Nov 09

CEO Tazminat Analizi

Larry Edwards'un ücretlendirmesi La Jolla Pharmaceutical'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2022n/an/a

US$4m

Mar 31 2022n/an/a

US$5m

Dec 31 2021US$2mUS$550k

US$20m

Sep 30 2021n/an/a

US$12m

Jun 30 2021n/an/a

US$3m

Mar 31 2021n/an/a

-US$16m

Dec 31 2020US$3mUS$208k

-US$39m

Tazminat ve Piyasa: Larry 'nin toplam tazminatı ($USD 2.39M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.44M ).

Tazminat ve Kazançlar: Larry 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Larry Edwards (50 yo)

2.1yrs

Görev süresi

US$2,389,409

Tazminat

Mr. Larry G. Edwards has been President and Chief Executive Officer at La Jolla Pharmaceutical Company since July 2020. Mr. Edwards serves as Director at La Jolla Pharmaceutical Company since October 29, 2...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Larry Edwards
President2.1yrsUS$2.39m0.048%
$ 74.5k
Michael Hearne
CFO & Secretary2.2yrsUS$504.10k0.041%
$ 63.4k
Paula Rusu
Vice President of Operations1.8yrsVeri yokVeri yok
Sandra Vedrick
Senior Director of Investor Relations & Human Resourcesno dataVeri yokVeri yok
Luke Seikkula
Senior Vice President of Pharmaceutical Operations3.5yrsVeri yokVeri yok
Lakhmir Chawla
Consultant7.1yrsUS$707.29kVeri yok
Stewart Kroll
Chief Development Officer2.7yrsVeri yokVeri yok
Mark Williams
Senior Vice President of Medical Affairs1.9yrsVeri yokVeri yok
Tony Hodges
Chief Medical Officerless than a yearVeri yokVeri yok

2.1yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim: LJPC 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.1 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Larry Edwards
President1.8yrsUS$2.39m0.048%
$ 74.5k
Kevin Tang
Chairman of the Board8yrsUS$105.86k0.45%
$ 696.6k
David Ramsay
Independent Director2.8yrsUS$165.86k0.40%
$ 622.0k
Tomas Ganz
Member of Scientific Advisory Board8.5yrsVeri yokVeri yok
Laura Douglass
Independent Director8.8yrsUS$165.86k0.0020%
$ 3.1k
Elizabeta Nemeth
Member of Scientific Advisory Board8.5yrsVeri yokVeri yok
Craig Johnson
Independent Director8.8yrsUS$180.86k0.048%
$ 74.6k
Robert Rosen
Independent Director8.1yrsUS$165.86k0%
$ 0
Paul Adams
Member of Advisory Board7.3yrsVeri yokVeri yok
Victor Gordeuk
Member of Advisory Board7.3yrsVeri yokVeri yok
Ashutosh Lal
Member of Advisory Board7.3yrsVeri yokVeri yok
Gordon McLaren
Member of Advisory Board7.3yrsVeri yokVeri yok

7.7yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: LJPC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.7 yıldır).